Clearmind Medicine Inc. is a psychedelic pharmaceutical biotech company. The Company is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The Company researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 15 patent families, including 27 granted patents and 24 pending applications. The portfolio spans a range of jurisdictions, including the United States, Europe, India, and China.
종목 코드 CMND
회사 이름Clearmind Medicine Inc
상장일Aug 10, 2021
CEODr. Adi Zuloff-Shani
직원 수- -
유형Ordinary Share
회계 연도 종료Aug 10
주소101-1220 West 6Th Avenue
도시VANCOUVER
증권 거래소NASDAQ Capital Market Consolidated
국가Canada
우편 번호V6H 1A5
전화16042601566
웹사이트https://www.clearmindmedicine.com/
종목 코드 CMND
상장일Aug 10, 2021
CEODr. Adi Zuloff-Shani
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음